Vol.

No.

October 12, 2018Oct 12, 2018

DOWNLOAD THE PDF

Cover Story

St. Jude and the World Health Organization collaborate in first-ever global alliance to boost cancer cure rates in children

By Matthew Bin Han Ong

St. Jude Children's Research Hospital and the World Health Organization have formed a collaboration, working with partners across the world, and aiming to cure at least 60 percent of children with cancer worldwide by 2030.

Conversation with The Cancer Letter

St. Jude's Downing: WHO effort can raise cure rates up to 60% for children with cancer

By Matthew Bin Han Ong

Conversation with The Cancer Letter

WHO's Ilbawi: St. Jude partnership can resolve inequality, capacity issues in childhood cancer

By Matthew Bin Han Ong

Letter To The Editor

Letter to the Editor 2018

Clinical Trials & Tribulations

Biomarker linked to increased survival rates among certain brain tumor patients

By Arnab Chakravarti

In Brief

Cancer biologist Steven Artandi to lead Stanford Cancer Institute, replacing outgoing director Beverly Mitchell

Allan Tsung named surgical oncology division director at Ohio State

Marc Hurlbert named chief science officer at Melanoma Research Alliance

Katzenellenbogen named Chuck and Tina Pagano Scholar at IU

Clinical Roundup

New ASTRO/ASCO/AUA guideline for early-stage prostate cancer supports use of shortened courses of radiation therapy

High-precision proton therapy more effective in some cancers when combined with thermal therapy

Cancer death disparities linked to poverty, lifestyle factors nationwide

Report: tobacco control must be highest priority in cancer control

Drugs & Targets

ODAC recommends approval of rituximab biosimilar

Myriad, Pfizer announce commercialization plan for talazoparib companion diagnostic

Foundation Medicine introduces liquid biopsy for solid tumors in patients with advanced cancer

Celyad announces agreement for Horizon Discovery's shRNA platform to develop next- gen allogeneic CAR-T therapies

Novitas Solutions approves coverage of UPMC-developed test for diagnosis of thyroid nodules

NCI Trials

NCI Trials for October

The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 50 | Issue 42 - November 08, 2024

St. Jude and the World Health Organization collaborate in first-ever global alliance to boost cancer cure rates in children

St. Jude's Downing: WHO effort can raise cure rates up to 60% for children with cancer

WHO's Ilbawi: St. Jude partnership can resolve inequality, capacity issues in childhood cancer

Letter to the Editor 2018

Biomarker linked to increased survival rates among certain brain tumor patients

In Brief

Cancer biologist Steven Artandi to lead Stanford Cancer Institute, replacing outgoing director Beverly Mitchell

Allan Tsung named surgical oncology division director at Ohio State

Marc Hurlbert named chief science officer at Melanoma Research Alliance

Katzenellenbogen named Chuck and Tina Pagano Scholar at IU

Clinical Roundup

New ASTRO/ASCO/AUA guideline for early-stage prostate cancer supports use of shortened courses of radiation therapy

High-precision proton therapy more effective in some cancers when combined with thermal therapy

Cancer death disparities linked to poverty, lifestyle factors nationwide

Report: tobacco control must be highest priority in cancer control

Drugs & Targets

ODAC recommends approval of rituximab biosimilar

Myriad, Pfizer announce commercialization plan for talazoparib companion diagnostic

Foundation Medicine introduces liquid biopsy for solid tumors in patients with advanced cancer

Celyad announces agreement for Horizon Discovery's shRNA platform to develop next- gen allogeneic CAR-T therapies

Novitas Solutions approves coverage of UPMC-developed test for diagnosis of thyroid nodules

NCI Trials

NCI Trials for October

Recent Issues

Renew today!

Subscriber content

Login